Nasdaq: IMNM
Immunome insiders
The officers, directors and 10% owners of Immunome, Inc. who hold the most stock, valued at the live IMNM price.
$16.61
IMNM today −$170K (−1.01%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 6
- Their IMNM stock
- $109M
- Market value
- $2.01B
- Held by ranked insiders
- 5.41%
Insiders by value of IMNM holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Isaac Barchas | Director | 4,165,824 | $69.2M | 3.44% | 2007th |
| 2 | Michael Rapp | Director | 1,071,172 | $17.8M | 0.88% | 5660th |
| 3 | Clay B. Siegall | President and CEO | 870,704 | $14.5M | 0.72% | 6141st |
| 4 | Philip Wagenheim | Director | 341,147 | $5.7M | 0.28% | 4856th |
| 5 | John L. Lamattina | Director | 66,953 | $1.1M | <0.1% | 9629th |
| 6 | Jean Jacques Bienaime | Director | 43,415 | $721K | <0.1% | 2620th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Immunome; see each profile for the filing.